Stewart Bluefarb syndrome: case report of a rare variant of acroangiodermatitis
Journal Title: Nasza Dermatologia Online - Year 2018, Vol 9, Issue 3
Abstract
Stewart Bluefarb syndrome is a rare acroangiodermatitis which occurs due to presence of arteriovenous malformations. It presents at birth or during early childhood as an erythematous to violaceous plaques over the dorsum of foot or ankle. It’s a benign condition but can mimic a malignant condition, Kaposi’s sarcoma. Histopathological differentiation between these two conditions is important. Investigations like doppler ultrasound are required to establish the diagnosis. In long standing cases, complications like ulceration, bleeding and secondary infections can occur. Treatment includes surgical correction of underlying arteriovenous malformation.
Authors and Affiliations
Guneet Awal
Melanoma and medical education: student’s perceptions of skin cancer screening in three medical schools
Background: This study evaluated how the level of medical education affected confidence of counseling on skin health, performing skin examinations, and the likelihood of using those skills in future screenings. Material...
Racjonalne wykorzystanie flukonazolu przez prowadzących oddział dermato-wenerologiczny w Tertiary Medical College Hospital w Bangladeszu
Badania przeprowadzono stawiając hipotezę, iż Flukonazol jest używany irracjonalnie, niezależnie od diagnozy. Materiały: wszyscy pacjenci prowadzeni byli przez lekarzy z Oddziału skórno-wenerologicznego z Enam Medical C...
Terra firma forme dermatosis and plica neuropathica – case report
Although Dirty Duncan Dermatosis and Plica Neuropathica are two different entities. Yet they have a common denominator of disturbed state of mind. Presenting here a case, who suffered from both, but forty years apart and...
Dubreuilh's melanosis or malignant lentigo
-
A novel nonsense ATP2C1 mutation causes Hailey-Hailey disease in a Tunisian family
Background: Hailey-Hailey disease (HHD) is an autosomal dominant blistering skin disorder that manifests in the third to fourth decade of life. The ATP2C1 has been identified as the pathogenic gene of this disease since...